Eurobio Scientific

Equities

ALERS

FR0013240934

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:35:13 2024-05-17 am EDT			5-day change	1st Jan Change
14.62 ^EUR	-0.95%		-1.08%	-11.18%

May. 08	Eurobio Scientific: agreement with Myriad Genetics	CF
May. 08	Eurobio Scientific to Buy Gene Expression Test for Breast Cancer	MT

Eurobio Scientific: agreement with Myriad Genetics

May 08, 2024 at 09:31 am EDT

Eurobio Scientific announces the signature of an agreement to acquire all rights to the EndoPredict second-generation breast cancer gene expression test from Myriad Genetics.

Following this acquisition, Eurobio Scientific will grant Myriad Genetics a license to manufacture, sell and distribute the EndoPredict breast cancer screening test for laboratory developed tests (LDT), mainly in the United States.

In addition, Myriad Genetics will grant Eurobio Scientific a license to manufacture, sell and distribute the Prolaris prostate cancer screening test kit. Completion of the transaction is scheduled for next July.

Copyright (c) 2024 CercleFinance.com. All rights reserved.

Go to the original article.
Legal disclaimer

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	MYRIAD GENETICS, INC.	25.31 USD	+2.84%	-0.63%	2.29B
	EUROBIO SCIENTIFIC	14.62 EUR	-0.95%	-1.08%	163M

Latest news about Eurobio Scientific

Eurobio Scientific: agreement with Myriad Genetics	May. 08	CF
Eurobio Scientific to Buy Gene Expression Test for Breast Cancer	May. 08	MT
Eurobio Scientific Société anonyme signed a definitive agreement to acquire EndoPredict business of Myriad Genetics, Inc for $10 million.	May. 06	CI
Eurobio Scientific: 2023 results down, share price falls	Apr. 11	CF
Eurobio Scientific Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 10	CI
Eurobio Scientific Société anonyme acquired Alpha Biotech Ltd.	Jan. 29	CI
Eurobio Scientific: cancellation of treasury shares	Jan. 10	CF
OSE Immuno: collaboration agreement with GenDx	Nov. 21	CF
Eurobio Scientific Appoints Catherine Courboillet to the Board of Directors	Nov. 07	CI
Eurobio Scientific Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-11	CI
Eurobio Scientific Société anonyme(ENXTPA:ALERS) dropped from S&P Global BMI Index	23-09-18	CI
Q-linea Shares Gain Amid Progress of French Distribution Deal	23-07-27	MT
Eurobio Scientific Société anonyme acquired Diagnostic International Distribution SPA from Barbara Maffioli and Enrico Maffioli.	23-07-04	CI
Q-linea Expands European Reach with Distribution Partnership in France	23-06-13	MT
Q-linea AB Signs Distribution Partnership for ASTar Instrument and Consables for France with Eurobio Scientific	23-06-13	CI
Eurobio Scientific: market applauds Italian acquisition	23-06-13	CF
Eurobio Scientific Strikes Deal to Buy Italy's Diagnostic International Distribution	23-06-13	MT
Eurobio Scientific Société anonyme signing of an agreement to acquire Diagnostic International Distribution SPA.	23-06-12	CI
Global markets live: Agilent, Intuit, Palo Alto, Kohl's, Urban Outfitters...	23-05-24
Eurobio Scientific Secures IVDR CE Marking for Diagnostic Tests	23-05-24	MT
Eurobio Scientific: IVDR CE markings for PCR tests	23-05-23	CF
Eurobio Scientific Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-05	CI
EchiumBio Takes 2% Stake in Eurobio Scientific	23-02-15	MT
Eurobio Scientific: EchiumBio Holding acquires 2% of share capital	23-02-14	CF
Eurobio Scientific's New CFO Formally Takes Office	23-02-09	MT

Chart Eurobio Scientific

Duration

Period

More charts

Company Profile

Eurobio Scientific is a key player in the field of specialty in vitro diagnostics. It is involved from research to manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, Eurobio Scientific has established its own distribution network and a portfolio of proprietary products in the molecular biology field. The group has approximately 286 employees, three production units based in the Paris region, in Germany and in the United States, and subsidiaries in Dorking in the United Kingdom, Sissach in Switzerland, Bünde in Germany and Utrecht in the Netherlands.

Sector

Biotechnology & Medical Research

Calendar

2024-06-12 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Eurobio Scientific

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.62 EUR

Average target price

30 EUR

Spread / Average Target

+105.20%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
EUROBIO SCIENTIFIC	-11.18%	163M
MODERNA, INC.	+33.63%	50.93B
IQVIA HOLDINGS INC.	-0.09%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-4.96%	29.18B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	18.9B
BIO-TECHNE CORPORATION	+8.61%	13.21B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.17B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B

Other Biotechnology & Medical Research